Why Baudax Bio Shares Are Trading Higher By 60%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Gainers Baudax Bio, Inc. (NASDAQ:BXRX) shares surged 59.7% to $5.03 after the company announced the outcome of its first interim analysis in a Phase II trial of BX1000 for neuromuscular blockade in p
Ainos and Tah-An Sign MoU To Explore Manufacture Of VELDONA Animal Investigational New Drug
Ainos advances commercialization of its VELDONA low-dose interferon treatment through strategic partnershipsAinos intends to begin clinical trials into VELDONA's potential veterinary applications in t
Ainos CEO Says 'Sharpening Focus' on Advancing Commercialization
Ainos Says On Jan. 5, 2023 Co. Received Notice Of Delisting Or Failure To Satisfy Continued Listing Rule Or Standard From Nasdaq
Ainos Says On Jan. 5, 2023 Co. Received Notice Of Delisting Or Failure To Satisfy Continued Listing Rule Or Standard From Nasdaq
12 Health Care Stocks Moving In Thursday's Intraday Session
GainersVapotherm (NYSE:VAPO) shares rose 44.2% to $1.28 during Thursday's regular session. As of 12:30 EST, this security is trading at a volume of 7.8 million shares, making up 2565.9% of its average
12 Health Care Stocks Moving In Tuesday's Intraday Session
GainersOtonomy (NASDAQ:OTIC) shares increased by 114.7% to $0.23 during Tuesday's regular session. The current volume of 184.8 million shares is 6152.7% of Otonomy's average full-day volume over the l
12 Health Care Stocks Moving In Thursday's Pre-Market Session
GainersCosmos Holdings (NASDAQ:COSM) stock rose 45.1% to $0.48 during Thursday's pre-market session. The company's market cap stands at $39.8 million. NeuroBo Pharmaceuticals (NASDAQ:NRBO) shares incr
Ainos Says Preclinical Study Shows Potential of Veldona Drug for Medical Conditions in Cats, Dogs
06:21 AM EST, 11/21/2022 (MT Newswires) -- Ainos (AIMD) said Monday results from a preclinical study support the potential of its Veldona formulation to treat gingivostomatitis in cats and atopic derm
12 Health Care Stocks Moving In Friday's After-Market Session
GainersLumiraDx (NASDAQ:LMDX) stock moved upwards by 22.4% to $1.42 during Friday's after-market session. At the close, LumiraDx's trading volume reached 404.6K shares. This is 107.4% of its average v
Amarillo Biosciences GAAP EPS of -$0.51, Revenue of $1.75M
Loading...
No Stock Yet